Home β€Ί Healthcare β€Ί Biotechnology β€Ί Spatial Genomics And Transcriptomics Market

Spatial Genomics And Transcriptomics Market - Strategic Insights and Forecasts (2026-2031)

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY TYPE

5.1. Introduction

5.2. Spatial Genomics

5.2.1. In-Situ Hybridization

5.2.2. Next-Generation Sequencing

5.2.3. Others

5.3. Spatial Transcriptomics

5.3.1. Sequencing-Based

5.3.2. Probe-Based

5.3.3. Imaging-Based

6. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY APPLICATION

6.1. Introduction

6.2. Neurology

6.3. Oncology

6.4. Immunology

6.5. Developmental Biology

6.6. Others

7. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY END-USER

7.1. Introduction

7.2. Pharmaceutical & Biotech Companies

7.3. Academic & Research Institutes

7.4. Others

8. SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. 10x Genomics

10.2. Illumina, Inc.

10.3. S2 Genomics, Inc.

10.4. Bruker Spatial Biology, Inc.

10.5. Velsera

10.6. Bio-Techne

10.7. Akoya Biosciences

10.8. Standard BioTools

10.9. Vizgen Inc.

10.10. Agilent Technologies, Inc.

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

REPORT DETAILS

Report ID:KSI061615762
Published:Jan 2026
Pages:150
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us